mazindol has been researched along with dihydrotetrabenazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulay, D; Costentin, J; Leroux-Nicollet, I; Naudon, L | 1 |
| Albers, DS; Augood, SJ; Breakefield, XO; Hollingsworth, Z; Leung, J; Standaert, DG; Yang, L | 1 |
| Cleren, C; Costentin, J; Naudin, B | 1 |
3 other study(ies) available for mazindol and dihydrotetrabenazine
| Article | Year |
|---|---|
Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carrier Proteins; Chromatography, High Pressure Liquid; Citalopram; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Excitatory Amino Acid Agonists; Homovanillic Acid; Hydroxyindoleacetic Acid; Kainic Acid; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2001 |
Dopamine transmission in DYT1 dystonia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autoradiography; Basal Ganglia; Benzamides; Benzazepines; Binding Sites; Carrier Proteins; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dystonia; Family Health; Homovanillic Acid; Humans; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Chaperones; Neuropeptides; Synaptic Transmission; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins | 2004 |
Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
Topics: 1-Methyl-4-phenylpyridinium; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Binding Sites; Body Temperature; Dopamine; Drug Administration Routes; Drug Interactions; Hypothalamus; Hypothermia; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Neostriatum; Neurons; Neuropeptides; Neurotoxins; Oxidopamine; Reserpine; Substantia Nigra; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |